MicroSafe Group

MicroSafe is a global biotech and healthcare company focused on infection prevention and hospital-grade disinfection solutions through its patented Microcyn technology (stabilized hypochlorous acid). Its lead product, Nanocyn Disinfectant & Sanitiser, is commercial-stage, globally approved (TGA, FDA, EPA, CE), and TGA-approved for rapid, non-toxic disinfection against a broad range of pathogens, including SARS-CoV-2, Candida auris, and Clostridium difficile, with extensive use in hospitals and healthcare settings in over 25 countries. Nanocyn achieves up to 6-log microbial reduction within 30 seconds for most pathogens and 10 minutes for harder-to-eradicate pathogens like C. auris and C. difficile.